Wall Street Jedi
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Wall Street Jedi
No Result
View All Result
Home Economy

Kraken Rolls Out Commission-Free Stock Trading

by
April 21, 2025
in Economy
0
Kraken Rolls Out Commission-Free Stock Trading
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

Kraken Rolls Out Commission-Free Stock Trading

On April 14, 2025, Kraken, a leading cryptocurrency exchange, announced the official launch of commission-free stock trading for over 11,000 U.S.-listed stocks and exchange-traded funds (ETFs). This bold move signals Kraken’s strategic expansion beyond cryptocurrencies and into the realm of traditional financial markets. By bridging the gap between crypto and equities, Kraken is setting a new standard for what modern financial platforms can offer.

Kraken Stock Trading: A Hybrid Financial Approach

Initially available in select U.S. states like New Jersey and Connecticut, Kraken stock trading allows users to invest in equities without paying any trading commissions. The company has confirmed plans to roll out the service to more states and international markets, including the UK, Europe, and Australia.

Arjun Sethi, Kraken’s Co-CEO, said, “Expanding into equities is a natural step for us and paves the way for the tokenization of real-world assets. The future of trading is borderless, built on crypto rails, and accessible to all.”

The Future of Commission-Free Trading

This move reflects a broader industry trend: the convergence of digital and traditional financial systems. With the addition of commission-free trading, Kraken is no longer just a crypto exchange—it’s evolving into a full-spectrum financial services platform. This positions Kraken to compete with both fintech firms and legacy brokers by offering an all-in-one experience to tech-savvy investors.

Moreover, Kraken’s plans don’t stop at equities. The exchange is also working toward integrating tokenized stocks and payment services into its ecosystem, reinforcing its mission to democratize access to financial tools globally.

Investor Takeaway

Kraken’s latest initiative not only appeals to current crypto users but also attracts traditional investors looking for commission-free, easy-to-access investment options. As this hybrid approach gains traction, Kraken’s model could become a blueprint for future financial innovation.

Source: Reuters

The post Kraken Rolls Out Commission-Free Stock Trading appeared first on FinanceBrokerage.

Previous Post

Bitcoin Rebounds to $83,404 Amid Renewed Investor Confidence

Next Post

Bitcoin Nears $85K Amid Market Optimism

Next Post
Bitcoin Nears $85K Amid Market Optimism

Bitcoin Nears $85K Amid Market Optimism

  • Trending
  • Comments
  • Latest
A piece of the illegally felled Sycamore Gap tree is going on display – and you can hug it

A piece of the illegally felled Sycamore Gap tree is going on display – and you can hug it

July 14, 2025
American creating deepfakes targeting Harris works with Russian intel, documents show

American creating deepfakes targeting Harris works with Russian intel, documents show

October 23, 2024
Almonty Acquires Montana Tungsten Project as US Seeks to Revive Domestic Supply

Almonty Acquires Montana Tungsten Project as US Seeks to Revive Domestic Supply

October 29, 2025
BHP’s Copper and Iron Ore Assets Deliver “Strong” Results

BHP’s Copper and Iron Ore Assets Deliver “Strong” Results

January 21, 2026
Cartier Cuts 7.1 g/t Au over 8.0 m at Portal ; New Shallow High-Grade Gold Zone Discovered

Cartier Cuts 7.1 g/t Au over 8.0 m at Portal ; New Shallow High-Grade Gold Zone Discovered

0
McDonald’s where Trump served fries hit with flurry of bad Yelp reviews

McDonald’s where Trump served fries hit with flurry of bad Yelp reviews

0
In close race that could tip House, candidates fight for the center

In close race that could tip House, candidates fight for the center

0
As Democratic icons stump for Harris, GOP elders keep distance from Trump

As Democratic icons stump for Harris, GOP elders keep distance from Trump

0
Cartier Cuts 7.1 g/t Au over 8.0 m at Portal ; New Shallow High-Grade Gold Zone Discovered

Cartier Cuts 7.1 g/t Au over 8.0 m at Portal ; New Shallow High-Grade Gold Zone Discovered

March 12, 2026
Pan African To Acquire Emmerson Resources in US$218 Million Gold Deal

Pan African To Acquire Emmerson Resources in US$218 Million Gold Deal

March 11, 2026
Homerun Resources Inc. and UC Davis Produce Fused Silica Glass from SME Silica Sand Using Fast Joule Heating and File Patent Application for Femtosecond Silica Purification Process

Homerun Resources Inc. and UC Davis Produce Fused Silica Glass from SME Silica Sand Using Fast Joule Heating and File Patent Application for Femtosecond Silica Purification Process

March 10, 2026
InMed Provides Update on Pharmaceutical Development Programs – Advancing Lead Drug Candidates Towards IND and Clinical Trial

InMed Provides Update on Pharmaceutical Development Programs – Advancing Lead Drug Candidates Towards IND and Clinical Trial

March 9, 2026

Recent News

Cartier Cuts 7.1 g/t Au over 8.0 m at Portal ; New Shallow High-Grade Gold Zone Discovered

Cartier Cuts 7.1 g/t Au over 8.0 m at Portal ; New Shallow High-Grade Gold Zone Discovered

March 12, 2026
Pan African To Acquire Emmerson Resources in US$218 Million Gold Deal

Pan African To Acquire Emmerson Resources in US$218 Million Gold Deal

March 11, 2026
Homerun Resources Inc. and UC Davis Produce Fused Silica Glass from SME Silica Sand Using Fast Joule Heating and File Patent Application for Femtosecond Silica Purification Process

Homerun Resources Inc. and UC Davis Produce Fused Silica Glass from SME Silica Sand Using Fast Joule Heating and File Patent Application for Femtosecond Silica Purification Process

March 10, 2026
InMed Provides Update on Pharmaceutical Development Programs – Advancing Lead Drug Candidates Towards IND and Clinical Trial

InMed Provides Update on Pharmaceutical Development Programs – Advancing Lead Drug Candidates Towards IND and Clinical Trial

March 9, 2026

Disclaimer: WallStreetJedi.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 wallstreetjedi.com | All Rights Reserved

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 wallstreetjedi.com | All Rights Reserved